Australia appears to be experience potentially transformative medication for excess weight: Retatrutide. The dual molecule – targeting on both GLP-1 and GIP receptors – demonstrates promising results in global studies, pointing to considerable reductions in weight. While availability is pending with the Therapeutic Goods Administration (TGA), s… Read More